StonvexLoading…
StonvexStonvexStonvexCore line items from NBTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $182.95M | $165.71M | $144.74M | $150.66M |
Operating Income | $219.44M | $179.46M | $153.46M | $196.16M |
Net Income | $169.24M | $140.64M | $118.78M | $152.00M |
EPS (Diluted) | $3.33 | $2.97 | $2.65 | $3.52 |
Total Assets | $16.00B | $13.79B | $13.31B | $11.74B |
Total Liabilities | $14.10B | $12.26B | $11.88B | $10.57B |
Cash & Equivalents | $487.12M | $284.06M | $205.19M | $197.35M |
Free Cash Flow OCF − CapEx | $218.92M | $176.82M | $148.20M | $176.21M |
Shares Outstanding | 50.88M | 47.43M | 44.77M | 43.18M |